FDA Inspection 806330 — Octapharma Plasma, Inc.

Octapharma Plasma, Inc. — FEI 3005621840

The FDA completed an inspection of Octapharma Plasma, Inc. on October 25, 2012 in Monroe, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 25, 2012
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Monroe, LA (United States)